Session Details
[SY6]Symposium 6 : USJCMSP Hepatitis Panel: Achievement and Future Challenges in Hepatitis Research
Tue. Nov 3, 2026 3:15 PM - 5:45 PM JST
Tue. Nov 3, 2026 6:15 AM - 8:45 AM UTC
Tue. Nov 3, 2026 6:15 AM - 8:45 AM UTC
Room 1 (2F International Conference Room)
Chair: Tatsuya Kanto (The Research Center for Hepatitis and Immunology, National Institute of Global Health and Medicine, Japan Institute for Health)
Arash Grakoui (Emory National Primate Center / Emory Center for AIDS Research / Winship Cancer Institute ), Eui-Cheol Shin (KAIST (Korea Advanced Institute of Science and Technology)), Sachiyo Yoshio (National Institute of Global Health and Medicine, Japan Institute for Health Security Department of Human Immunology and Translational Research)
Motoyuki Otsuka (Department of Gastroenterology and Hepatology, Academic Fields of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University), Toru Okamoto (Department of Virology, Juntendo University School of Medicine)
Arash Grakoui (Emory National Primate Center / Emory Center for AIDS Research / Winship Cancer Institute ), Eui-Cheol Shin (KAIST (Korea Advanced Institute of Science and Technology)), Sachiyo Yoshio (National Institute of Global Health and Medicine, Japan Institute for Health Security Department of Human Immunology and Translational Research)
Motoyuki Otsuka (Department of Gastroenterology and Hepatology, Academic Fields of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University), Toru Okamoto (Department of Virology, Juntendo University School of Medicine)
[SY6-1]Therapeutic HBV vaccine efficacy through ancestral mismatched T cell epitopes
*Nina Le Bert1 (1. Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore)
[SY6-2]Mechanistic Insights into CD8+ T-Cell Tolerance in HBV-Expressing Livers - Multiple Paths to Dysfunction
*Keigo Kawashima1,2, Saori Tachibana1, Lin Sun1, Masaaki Toyama1, Tomohiro Takano2, Takayuki Matsumura2, Yoshimasa Takahashi2, Masanori Isogawa1 (1. Department of Virology II, National Institute of Infectious Diseases, Japan Institute for Health Security, 2. Research Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security)
[SY6-3]Targeting NTCP for HBV and HDV infection: development of susceptible cell lines and Small-Molecule Discovery
Sehee Park1, Shuo Wang2, Jae-Hyun Park3, Peng Zhan2, *Chunkyu Ko1 (1. Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea, 2. Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, China, 3. Department of Molecular Cell Biology, Graduate School of Basic Medical Science, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea)
[SY6-4]Fumarylacetoacetate Hydrolase as a Novel Host Factor Regulating HBV Replication and the Antiviral Potential of Dimethyl Fumarate
*Takuto Nosaka1, Tatsushi Naito1, Shouichi Namikawa1, Yosuke Murata1, Yu Akazawa1, Tomoko Tanaka1, Kazuto Takahashi1, Yasunari Nakamoto1 (1. Department of Gastroenterology, Faculty of Medical Sciences, University of Fukui)
Group Photo
[SY6-5]The immunological and structural basis of hepaciviral adaptation
*John Gridley1 (1. Emory University)
[SY6-6]RNA decay, innate Immunity, and the control of hepatitis D virus infection
*Senko Tsukuda1,2, Medhi Boutasbih1, Peter Balfe3, Jane A McKeating1,3 (1. Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, 2. National Institute of Infectious Diseases, Japan Institute for Health Security, 3. Nuffield Department of Medicine, University of Oxford)
[SY6-7]Single-cell landscape of immune responses in patients with acute hepatitis A virus infection
*Hosun Yu1, Hoyoung Lee1, So-Young Kim1, Eui-Cheol Shin1 (1. Graduate School of Medical Science and Engineering, KAIST)
[SY6-8]A CRISPR-based Genome-wide Loss-of-function Screen Defines a Role of Host Metabolism in Regulating Hepatitis B Virus Infection
*Tadashi Inuzuka1, Jake T Liang2 (1. Kyoto University, Graduate School of Medicine, Gastroenterology and Hepatology Department, 2. National Institute of Diabetes and Digestive and Kidney Diseases・Liver Diseases Branch)